0.3133
price up icon2.69%   0.0082
 
loading
Fibrogen Inc stock is traded at $0.3133, with a volume of 451.72K. It is up +2.69% in the last 24 hours and up +7.59% over the past month. FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
See More
Previous Close:
$0.3051
Open:
$0.3021
24h Volume:
451.72K
Relative Volume:
0.48
Market Cap:
$29.06M
Revenue:
$147.75M
Net Income/Loss:
$-284.23M
P/E Ratio:
-0.1069
EPS:
-2.93
Net Cash Flow:
$-317.54M
1W Performance:
+8.94%
1M Performance:
+7.59%
6M Performance:
-8.42%
1Y Performance:
-73.67%
1-Day Range:
Value
$0.3021
$0.3228
1-Week Range:
Value
$0.28
$0.3228
52-Week Range:
Value
$0.18
$1.53

Fibrogen Inc Stock (FGEN) Company Profile

Name
Name
Fibrogen Inc
Name
Phone
415-978-1200
Name
Address
350 BAY STREET, SAN FRANCISCO, CA
Name
Employee
225
Name
Twitter
@FibroGenInc
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
FGEN's Discussions on Twitter

Compare FGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FGEN
Fibrogen Inc
0.3133 29.06M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-08-23 Downgrade BofA Securities Neutral → Underperform
Jun-26-23 Downgrade BofA Securities Buy → Neutral
Jun-26-23 Downgrade Raymond James Outperform → Mkt Perform
Jun-26-23 Downgrade Stifel Buy → Hold
Jun-26-23 Downgrade William Blair Outperform → Mkt Perform
Jun-02-23 Upgrade Stifel Hold → Buy
Jan-31-23 Upgrade William Blair Mkt Perform → Outperform
Jan-26-23 Upgrade Raymond James Mkt Perform → Outperform
Jan-05-23 Upgrade BofA Securities Neutral → Buy
Sep-22-21 Downgrade Goldman Neutral → Sell
Aug-20-21 Upgrade Raymond James Underperform → Mkt Perform
Jul-16-21 Downgrade BofA Securities Buy → Neutral
Jul-16-21 Downgrade Stifel Buy → Hold
Apr-07-21 Downgrade H.C. Wainwright Buy → Neutral
Apr-07-21 Downgrade Mizuho Buy → Neutral
Mar-31-21 Upgrade BofA Securities Neutral → Buy
Mar-02-21 Downgrade Jefferies Buy → Hold
Feb-01-21 Initiated H.C. Wainwright Buy
Oct-26-20 Initiated Raymond James Underperform
Jul-10-20 Resumed Stifel Buy
May-01-20 Initiated Cowen Market Perform
Apr-27-20 Initiated BofA/Merrill Neutral
May-29-19 Resumed Goldman Neutral
May-10-19 Downgrade William Blair Outperform → Mkt Perform
Apr-12-19 Initiated Piper Jaffray Neutral
Feb-11-19 Resumed Stifel Buy
Dec-19-18 Upgrade Citigroup Neutral → Buy
Aug-08-17 Reiterated Leerink Partners Outperform
Aug-08-17 Reiterated Stifel Buy
Jul-21-17 Downgrade Goldman Buy → Neutral
Jul-11-17 Initiated Jefferies Buy
Feb-11-16 Upgrade Credit Suisse Neutral → Outperform
Jan-21-16 Initiated Credit Suisse Neutral
Dec-04-15 Initiated Citigroup Buy
Sep-23-15 Initiated Lake Street Hold
Jul-29-15 Initiated Citigroup Buy
Jul-20-15 Upgrade Goldman Neutral → Buy
Dec-09-14 Initiated Stifel Buy
View All

Fibrogen Inc Stock (FGEN) Latest News

pulisher
May 19, 2025

FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 17, 2025

FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline - MSN

May 17, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

FibroGen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Negative Outlook for FibroGen Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

FibroGen’s Earnings Call: Strategic Gains Amid Revenue Woes - TipRanks

May 15, 2025
pulisher
May 15, 2025

FibroGen (NASDAQ:FGEN) Earns Buy Rating from HC Wainwright - Defense World

May 15, 2025
pulisher
May 14, 2025

FibroGen (FGEN) Boosts Sale Proceeds from Chinese Division - GuruFocus

May 14, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwrigh - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc earnings beat by $0.15, revenue fell short of estimates - Investing.com UK

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

FibroGen (FGEN) Receives Reaffirmed Buy Rating from HC Wainwright & Co. | FGEN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid Revenue Decline - GuruFocus

May 13, 2025
pulisher
May 13, 2025

FibroGen Reports Q1 2025 Earnings and Strategic Updates - TipRanks

May 13, 2025
pulisher
May 12, 2025

Earnings call transcript: FibroGen Q1 2025 sees revenue drop, stock rises - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

FibroGen Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $2.7M, EPS Misses with $0.16 Loss - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimat - GuruFocus

May 12, 2025
pulisher
May 12, 2025

FibroGen: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
pulisher
May 12, 2025

FIBROGEN INC SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 11, 2025

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World

May 11, 2025
pulisher
May 10, 2025

FibroGen (FGEN) Set to Release Q1 Earnings Results - GuruFocus

May 10, 2025
pulisher
May 06, 2025

FibroGen to Report First Quarter 2025 Financial Results - The Manila Times

May 06, 2025
pulisher
May 05, 2025

FibroGen Q1 2025 Earnings Call: Key Details for May 12 Financial Results Release - Stock Titan

May 05, 2025
pulisher
May 05, 2025

FibroGen, Inc. to Announce Q1 2025 Financial Results and Host Conference Call on May 12 - Nasdaq

May 05, 2025
pulisher
May 03, 2025

FibroGen (FGEN) to Release Quarterly Earnings on Monday - Defense World

May 03, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 01, 2025

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

May 01, 2025
pulisher
Apr 27, 2025

Investor Network: FibroGen, Inc. to Host Earnings Call - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Sells 97,900 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

FGEN Stock Price and Chart — NASDAQ:FGEN - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

Investors Don't See Light At End Of FibroGen, Inc.'s (NASDAQ:FGEN) Tunnel And Push Stock Down 26% - simplywall.st

Apr 08, 2025
pulisher
Apr 04, 2025

Q1 Earnings Estimate for FibroGen Issued By William Blair - Defense World

Apr 04, 2025

Fibrogen Inc Stock (FGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Fibrogen Inc Stock (FGEN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
Adib Deyaa
Chief Medical Officer
Jun 12 '24
Buy
1.17
22,123
25,884
82,123
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Cap:     |  Volume (24h):